- Report
- November 2026
- 506 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 230 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 385 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 505 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 204 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 279 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 189 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 220 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 195 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 353 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 475 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 331 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 265 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 221 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 335 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 219 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 171 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 295 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 458 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 439 Pages
Global
From €5493EUR$5,850USD£4,582GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more